ArticleOncology letters2012

Downregulation of BCSG1 may correlate with better outcome of neoadjuvant chemotherapy for triple-negative breast cancer.

Jinsong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.